NCT01193413

Brief Summary

Early diagnosis of secondary infection of necrotic tissue in severe acute pancreatitis is extremely important. The investigators evaluated whether the level of soluble TREM-1 (sTREM-1) in fine needle aspiration (FNA) fluid from patients who suspected infection is a good marker of secondary infection of necrotic tissue and an indicator of the proper treatment between drainage and necrosectomy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2008

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2008

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2009

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2009

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

August 30, 2010

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 2, 2010

Completed
Last Updated

September 2, 2010

Status Verified

September 1, 2009

Enrollment Period

1 year

First QC Date

August 30, 2010

Last Update Submit

September 1, 2010

Conditions

Keywords

acute pancreatitisDrainagePancreatic surgeryBiological Markers/analysisInfection diagnosisROC CurveSensitivity and SpecificityEndoscopic ultrasonography

Outcome Measures

Primary Outcomes (1)

  • The level of sTREM-1 in fine needle aspiration fluid

    The fluid level of sTREM-1 was used to diagnose the secondary infection of necrotic tissues in severe acute pancreatitis and select the proper treatment between single drainage and necrosectomy.

    more than 14 days after entry

Secondary Outcomes (5)

  • The fluid level of Interleukin-6

    more than 14 days after entry

  • The fluid level of tumor necrosis factor-α

    more than 14 days after entry

  • The serum level of sTREM-1

    more than 14 days after entry

  • The serum level of C-reactive protein

    more than 14 days after entry

  • The level of leukocyte count and neutrophil percentage

    more than 14 days after entry

Study Arms (3)

Non-infected necrosis group

There is no necrosis infection in severe acute pancreatitis.

Single drainage group

The patients with necrosis infection in severe acue pancreatitis were cured by single drainage.

Combined surgery group

If there was no clinical improvement after single drainage about 7 days, an open necrosectomy was performed in the patients with necrosis infection.

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients 18 years of age or older who were hospitalized in our medical pancreatic intensive care unit (PICU) for least two weeks were enrolled in the study if there was a clinical suspicion of secondary infection of necrotic tissue.

You may qualify if:

  • years of age or older
  • Diagnosis of severe pancreatitis
  • Pancreatic or peripancreatic necrosis
  • Body temperature at least 38.3°C
  • Leukocytosis (more than 10,000 leukocytes per cubic millimeter) or leukopenia (fewer than 4000 leukocytes per cubic millimeter)

You may not qualify if:

  • A flare-up of chronic pancreatitis
  • End-stage chronic diseases (including pancreatic and bile duct cancer)
  • Previous drainage or surgery for confirmed or suspected infected necrosis
  • An acute intraabdominal event (e.g., perforation of a visceral organ, bleeding, or the abdominal compartment syndrome)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Changhai Hospital, Second Military Medical University

Shanghai, 200433, China

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

The FNA fluid specimens were performed under ultrasound or CT guidance, using a 18G needle attached to a 15 ml eppendorf tube. One percent xylocaine was used for local anaesthesia. Under real-time visualization, the needle was directed into the tissue part of the necrosis or pseudocyst.

MeSH Terms

Conditions

PancreatitisHypersensitivity

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System DiseasesImmune System Diseases

Study Officials

  • zhaoshen li, MD

    Changhai Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 30, 2010

First Posted

September 2, 2010

Study Start

July 1, 2008

Primary Completion

July 1, 2009

Study Completion

November 1, 2009

Last Updated

September 2, 2010

Record last verified: 2009-09

Locations